Clinical Trial Update: COVID-19 Vaccine Responses in PIDD Subjects

View source ↗

Summary

This clinical trial update describes COVID-19 vaccine responses in patients with primary immunodeficiency diseases (PIDD), including X-linked agammaglobulinemia…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Antibody Deficiencies
• Common Variable Immunodeficiency
• Hypogammaglobulinemia
• Immunodeficiency
• X-linked Agammaglobulinemia

Snippet

Sponsor: Duke University | Conditions: X-linked Agammaglobulinemia, XLA | Status: ACTIVE_NOT_RECRUITING